From: In situ characterization of stem cells-like biomarkers in meningiomas
Marker(s) | Grade | Mean | STD error | P value |
---|---|---|---|---|
Nestin+ | GI | 29.45 | 5.70 | 0.231 |
 | GII/III | 39.22 | 5.73 |  |
Ki67+ | GI | 0.77 | 0.17 | 0.019* |
 | GII/III | 2.72 | 0.78 |  |
CD133+ | GI | 36.60 | 6.22 | 0.770 |
 | GII/III | 39.11 | 5.86 |  |
Sox2+ | GI | 12.45 | 2.76 | 0.929 |
 | GII/III | 12.82 | 3.22 |  |
Vimentin+ | GI | 83.13 | 4.31 | 0.016* |
 | GII/III | 94.56 | 1.57 |  |
Frizzled9+ | GI | 11.82 | 2.35 | 0.000** |
 | GII/III | 31.23 | 4.10 |  |
GFAP+ | GI | 49.11 | 5.80 | 0.000** |
 | GII/III | 78.03 | 3.28 |  |
BIIITubulin+ | GI | 30.65 | 5.16 | 0.033* |
 | GII/III | 47.01 | 5.49 |  |
SSEA4+ | GI | 75.70 | 4.57 | 0.053 |
 | GII/III | 87.11 | 3.57 |  |
Olig2+ | GI | 55.33 | 5.02 | 0.072 |
 | GII/III | 67.55 | 4.43 |  |
Nestin+Ki67+ | GI | 0.51 | 0.16 | 0.080 |
 | GII/III | 1.23 | 0.37 |  |
Nestin+Ki67− | GI | 28.94 | 5.59 | 0.258 |
 | GII/III | 37.98 | 5.63 |  |
Nestin−Ki67+ | GI | 0.26 | 0.08 | 0.037* |
 | GII/III | 1.49 | 0.56 |  |
CD133+Sox2+ | GI | 11.73 | 2.71 | 0.039* |
 | GII/III | 5.48 | 1.20 |  |
CD133+Sox2− | GI | 24.87 | 4.41 | 0.224 |
 | GII/III | 33.63 | 5.61 |  |
CD133−Sox2+ | GI | 0.72 | 0.31 | 0.023* |
 | GII/III | 7.35 | 2.77 |  |
Vimentin+FZD9+ | GI | 11.80 | 2.36 | 0.000** |
 | GII/III | 31.08 | 4.12 |  |
Vimentin+FZD9− | GI | 71.34 | 3.87 | 0.159 |
 | GII/III | 63.48 | 3.95 |  |
Vimentin−FZD9+ | GI | 0.03 | 0.02 | 0.125 |
 | GII/III | 0.15 | 0.08 |  |
SSEA4+SOX2+ | GI | 12.57 | 2.50 | 0.565 |
 | GII/III | 10.59 | 2.36 |  |
SSEA4+SOX2− | GI | 63.13 | 4.12 | 0.021* |
 | GII/III | 76.52 | 3.91 |  |
SSEA4−SOX2+ | GI | 0.07 | 0.05 | 0.539 |
 | GII/III | 0.03 | 0.03 |  |
SSEA4+Olig2+ | GI | 49.81 | 5.42 | 0.035* |
 | GII/III | 64.64 | 4.29 |  |
SSEA4+Olig2- | GI | 29.15 | 3.51 | 0.324 |
 | GII/III | 23.97 | 3.85 |  |
SSEA4−Olig2+ | GI | 5.52 | 2.95 | 0.405 |
 | GII/III | 2.91 | 0.95 |  |